InvestSMART

INOVIQ Ltd (ASX: IIQ) - Announcements

- Current share price for IIQ : $0.200

ASX company news and announcements for INOVIQ Ltd (IIQ) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All INOVIQ Ltd (IIQ) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than INOVIQ Ltd (IIQ), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for INOVIQ Ltd (IIQ)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$28 Commercial and R&D Update 25 Nov 2022 9:18AM $0.540 $0.200 fallen by 62.96%
$28 Healthcare Conference Investor Presentation 10 Nov 2022 11:28AM $0.535 $0.200 fallen by 62.62%
$28 Appendix 4C - Statement pursuant to Listing Rule 4.7C.3 4 Nov 2022 9:54AM $0.535 $0.200 fallen by 62.62%
$28 IIQ Appendix 4C & Quarterly Activities Report-September 2022 28 Oct 2022 9:53AM $0.550 $0.200 fallen by 63.64%
$28 Canadian Patent Granted for BARD1 Technology 27 Oct 2022 2:06PM $0.550 $0.200 fallen by 63.64%
$28 Investor Presentation 27 Oct 2022 11:03AM $0.550 $0.200 fallen by 63.64%
$28 Notice of Annual General Meeting 27 Oct 2022 10:09AM $0.550 $0.200 fallen by 63.64%
$28 Receipt of R&D Tax Incentive Refund 14 Oct 2022 9:46AM $0.600 $0.200 fallen by 66.67%
$28 INOVIQ to Develop SubB2M-Based Test on Nicoya SPR Platform 13 Oct 2022 9:39AM $0.585 $0.200 fallen by 65.81%
$28 Appendix 4G and Corporate Governance Statement 12 Oct 2022 8:16AM $0.520 $0.200 fallen by 61.54%
$28 Appointment/Resignation of CFO and Company Secretary 6 Oct 2022 9:33AM $0.535 $0.200 fallen by 62.62%
$28 Notification of cessation of securities - IIQ 3 Oct 2022 3:16PM $0.555 $0.200 fallen by 63.96%
$28 Notice required under listing rule 3.13.1 3 Oct 2022 8:39AM $0.530 $0.200 fallen by 62.26%
$28 2022 Annual Report and update on results 28 Sep 2022 9:20AM $0.570 $0.200 fallen by 64.91%
$28 Appendix 4E and Preliminary Financial Report 30 Aug 2022 6:42PM $0.555 $0.200 fallen by 63.96%
$28 IIQ Investor Presentation 9 Aug 2022 10:18AM $0.635 $0.200 fallen by 68.50%
$28 INOVIQ Investor Briefing Invitation - June 2022 Quarter 4 Aug 2022 10:00AM $0.655 $0.200 fallen by 69.47%
$28 IIQ Appendix 4C & Quarterly Activities Report - June 2022 27 Jul 2022 9:12AM $0.670 $0.200 fallen by 70.15%
$28 Positive SubB2M IHC Results for Melanoma 26 Jul 2022 10:19AM $0.635 $0.200 fallen by 68.50%
$28 hTERT US Patent Granted 22 Jul 2022 9:00AM $0.640 $0.200 fallen by 68.75%
$28 INOVIQ Engages Sales Team to Accelerate EXO-NET Roll-out 21 Jul 2022 8:46AM $0.650 $0.200 fallen by 69.23%
$28 SubB2M US Patent Grant and Program Update 1 Jul 2022 9:53AM $0.390 $0.200 fallen by 48.72%
$28 INOVIQ&University of Sydney Present New EXO-NET Data at ISEV 27 May 2022 9:37AM $0.535 $0.200 fallen by 62.62%
$28 Change of Director's Interest - Philip Powell 16 May 2022 8:27AM $0.510 $0.200 fallen by 60.78%
$28 IIQ Investor Presentation 10 May 2022 8:38AM $0.555 $0.200 fallen by 63.96%

201 - 225 of 249 results

Page 9 of 10

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.